Multiple studies have demonstrated that nitric oxide (NO), produced via iNOS, can promote tumor cell proliferation, resistance to apoptosis, and contribute to an immunosuppressive TME in CRC (Ropponen et al., 2000; Zafirellis et al., 2010; Mandal, 2018). Here, NOS2 is linked to neoplasm.